[Increased risk of cardiovascular complications with oral hypoglycemic agents?].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000453:epidemiology; D002986:Clinical Trials as Topic; D003431:Cross-Cultural Comparison; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007391:International Cooperation; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000627:therapeutic use; D010919:Placebos; D011379:Prognosis; D014044:Tolbutamide / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D007328:Insulin; D010919:Placebos; D014044:Tolbutamide; D010629:Phenformin